In New Zealand, Maori and Pacific children have historically suffered high hospitalization rates for invasive pneumococcal disease (IPD), all cause pneumonia (ACP), and otitis media. Following the introduction of conjugate vaccines in the country, Maori and Pacific children’s rates of admission for IPD dropped by 79% and 67%, respectively, while significant reductions in ACP and otitis media admissions were also noted, resulting in reductions in disparities for these populations.
Full Citation:
Petousis-Harris, H., Howe, A.S., Paynter, J., et al.. 2018. Pneumococcal Conjugate Vaccines Turning the Tide on Inequity: A Retrospective Cohort Study of New Zealand Children Born 2006-2015. Clinical Infectious Diseases. 68(5).
Title of Article: Pneumococcal Conjugate Vaccines Turning the Tide on Inequity: A Retrospective Cohort Study of New Zealand Children Born 2006-2015
Author(s): Petousis-Harris, H., Howe, A.S., Paynter, J., et al.
Publication Year: 2018
Publication Name: Clinical Infectious Diseases
Publication Volume: 68(5)
Publication Source URL: https://www.ncbi.nlm.nih.gov/pubmed/30032236
DOI (Digital Object Identifier): 10.1093/cid/ciy570
Topics: Equity
Disease Vaccines: Pneumococcal disease/PCV/PPSV | Pneumonia
Immunization Terms: Hospitalizations
Countries: New Zealand
WHO Regions: Western Pacific